Literature DB >> 26986973

Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths.

Joachim Frost1, Trine Nordgård Løkken2, Arne Helland3, Ivar Skjåk Nordrum4, Lars Slørdal3.   

Abstract

This article presents levels and tissue distribution of codeine, codeine-6-glucuronide (C6G), norcodeine, morphine and the morphine metabolites morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) in post-mortem blood (peripheral and heart blood), vitreous fluid, muscle, fat and brain tissue in a series of 23 codeine-related fatalities. CYP2D6 genotype is also determined and taken into account. Quantification of codeine, C6G, norcodeine, morphine, M3G and M6G was performed with a validated solid phase extraction LC-MS method. The series comprise 19 deaths (83%) attributed to mixed drug intoxication, 4 deaths (17%) attributed to other causes of death, and no cases of unambiguous monointoxication with codeine. The typical peripheral blood concentration pattern in individual cases was C6G≫codeinenorcodeine>morphine, and M3G>M6G>morphine. In matrices other than blood, the concentration pattern was similar, although in a less systematic fashion. Measured concentrations were generally lower in matrices other than blood, especially in brain and fat, and in particular for the glucuronides (C6G, M3G and M6G) and, to some extent, morphine. In brain tissue, the presumed active moieties morphine and M6G were both below the LLOQ (0.0080mg/L and 0.058mg/L, respectively) in a majority of cases. In general, there was a large variability in both measured concentrations and calculated blood/tissue concentration ratios. There was also a large variability in calculated ratios of morphine to codeine, C6G to codeine and norcodeine to codeine in all matrices, and CYP2D6 genotype was not a reliable predictor of these ratios. The different blood/tissue concentration ratios showed no systematic relationship with the post-mortem interval. No coherent degradation or formation patterns for codeine, morphine, M3G and M6G were observed upon reanalysis in peripheral blood after storage.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Codeine; Forensic toxicology; Post-mortem; Tissue distribution; Toxicity

Mesh:

Substances:

Year:  2016        PMID: 26986973     DOI: 10.1016/j.forsciint.2016.02.051

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  4 in total

1.  Global genetic variation of select opiate metabolism genes in self-reported healthy individuals.

Authors:  F R Wendt; G Pathak; A Sajantila; R Chakraborty; B Budowle
Journal:  Pharmacogenomics J       Date:  2017-04-11       Impact factor: 3.550

Review 2.  Postmortem Toxicology of New Synthetic Opioids.

Authors:  Marta Concheiro; Rachel Chesser; Justine Pardi; Gail Cooper
Journal:  Front Pharmacol       Date:  2018-10-26       Impact factor: 5.810

3.  Morphine Binds Creatine Kinase B and Inhibits Its Activity.

Authors:  Ivan Weinsanto; Jinane Mouheiche; Alexis Laux-Biehlmann; François Delalande; Arnaud Marquette; Virginie Chavant; Florian Gabel; Sarah Cianferani; Alexandre Charlet; Marie-Odile Parat; Yannick Goumon
Journal:  Front Cell Neurosci       Date:  2018-12-03       Impact factor: 5.505

4.  Increased risk of death with codeine use in the elderly over 85 years old and patients with respiratory disease: A case-control study using retrospective insurance claims database.

Authors:  Ha Jin Tchoe; Sohyun Jeong; Dae Yeon Won; Jin Hyun Nam; Kyung-In Joung; Ju-Young Shin
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.